Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing

Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing

Developing reliable experimental models that can predict clinical response before treating the patient is a high priority in gynecologic cancer research, especially in advanced or recurrent endometrial and ovarian cancers. Patient-derived organoids (PDOs) represent such an opportunity. Herein, we de...

Full description

Bibliographic Details
Main Authors: Jianling Bi, Andreea M. Newtson, Yuping Zhang, Eric J. Devor, Megan I. Samuelson, Kristina W. Thiel, Kimberly K. Leslie
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
patient-derived organoids (PDOs)
endometrial cancer
ovarian cancer
drug sensitivity testing
personalized medicine
Online Access:https://www.mdpi.com/2072-6694/13/12/2901

Internet

https://www.mdpi.com/2072-6694/13/12/2901

Similar Items